News

EU drugs regulator to allow Novo Nordisk to include heart condition in Ozempic label
Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs
The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...
New Atlas23h
Ozempic maker announces not one, but three new weight-loss drugs
Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...
Danish firm Novo Nordisk set to launch Wegovy in India for weight loss
Danish company Novo Nordisk is set to launch Wegovy for weight loss, in India on Tuesday. The injectable product, called the ...
Kalkine Media5h
Novo Nordisk : EMA's CHMP Backs Ozempic Label Update
Novo Nordisk (NVO) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion to update the Ozempic (once-weekly ...
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...
Novo Nordisk preparing to launch weight-loss drug Wegovy in India
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
24/7 Wall St.3d
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee
The pharma giant will lose its patent protection on semaglutide, which is sold as Ozempic and Wegovy, in Canada after not ...